optavia and semaglutide A lot of people ask me how compares to GLP-1 medications. Here's my take… I'm not anti-GLP-1. I'm anti watching people lose weight lose muscle, energy, and healthy habits right Medifast, Inc. - Medifast Introduces

These clinical trials were conducted separately under different protocols and patient populations, and results should not be compared directly

Not everyone progresses at the same pace

And the two are not always mutually exclusive

In the landmark STEP 1 trial (Once-Weekly Semaglutide in Adults with Overweight or Obesity, Wilding and colleagues, New England Journal of Medicine , 2021), 1,961 adults who took weekly semaglutide (2.4 mg) plus lifestyle support lost a mean of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo, and 86% achieved at least 5% weight loss

Staying informed is not optional when using compounded medications, because the rules can change with relatively little notice